Meeder Advisory Services’s Zimmer Biomet ZBH Stock Holding History

Meeder Advisory Services’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,755	Closed	-$312K	–	645
2025 Q1	$312K	Sell	2,755 -275	-9%	-$29.4K	0.02%	449
2024 Q4	$320K	Buy	3,030 +910	+43%	+$97.6K	0.02%	434
2024 Q3	$229K	Sell	2,120 -262	-11%	-$28.6K	0.01%	495
2024 Q2	$259K	Buy	2,382 +489	+26%	+$57.6K	0.02%	435
2024 Q1	$250K	Buy	1,893 +6	+0.3%	+$749	0.03%	388
2023 Q4	$230K	Buy	+1,887	New	+$211K	0.03%	389
2023 Q3	–	Sell	-2,170	Closed	-$316K	–	450
2023 Q2	$316K	Sell	2,170 -4	-0.2%	-$544	0.03%	354
2023 Q1	$281K	Buy	2,174 +98	+5%	+$12.3K	0.03%	373
2022 Q4	$265K	Buy	+2,076	New	+$241K	0.03%	354

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Meeder Advisory Services's ZBH Position: Q2 2025 in Review

Meeder Advisory Services sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 2,755 shares — an estimated $312K sold.

Meeder Advisory Services first reported a position in ZBH in Q4 2022 and held it in 9 quarters. The position peaked at $320K in Q4 2024. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

Meeder Advisory Services reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
Meeder Advisory Services sold 2,755 Zimmer Biomet shares in Q2 2025, an estimated $312K.
Meeder Advisory Services first reported a position in Zimmer Biomet in Q4 2022 and held it in 9 quarters.
Meeder Advisory Services's Zimmer Biomet position peaked at $320K in Q4 2024.
934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on Meeder Advisory Services's 13F filing for Q2 2025, filed 7 Aug 2025.